A detailed history of Trust Point Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Trust Point Inc. holds 11,735 shares of ABBV stock, worth $2.37 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares
11,735
Previous 9,975 17.64%
Holding current value
$2.37 Million
Previous $1.71 Billion 35.45%
% of portfolio
0.17%
Previous 0.14%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024

BUY
$163.84 - $199.33 $288,358 - $350,820
1,760 Added 17.64%
11,735 $2.32 Billion
Q2 2024

Jul 24, 2024

SELL
$154.79 - $180.76 $74,763 - $87,307
-483 Reduced 4.62%
9,975 $1.71 Billion
Q1 2024

Apr 19, 2024

BUY
$159.82 - $182.1 $144,477 - $164,618
904 Added 9.46%
10,458 $1.9 Billion
Q4 2023

Jan 23, 2024

BUY
$137.6 - $154.97 $1.31 Million - $1.48 Million
9,554 New
9,554 $1.48 Billion

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $357B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Trust Point Inc. Portfolio

Follow Trust Point Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trust Point Inc., based on Form 13F filings with the SEC.

News

Stay updated on Trust Point Inc. with notifications on news.